The National Institute on Aging (NIA) awarded a $647,672 Project Grant (CFDA 93.866 - Aging Research) to the University of Washington to investigate "Mechanisms Underlying Reversal of Cardiac Aging by Urolithin A Treatment." The research aims to examine the role of mitochondrial dysfunction in the aging heart and how the compound urolithin A may help reverse age-related cardiovascular declines, including hypertrophy, diastolic dysfunction, and reduced contractility. The award period runs from September 15, 2024 to August 31, 2029. The University of Washington, a leading research institution, will be conducting this fundamental scientific investigation into the biology of cardiac aging and potential therapeutic interventions.
Generated 3/25/25, 6:00 AM